GlassScriptPhysician profile
Samantha Lacroce
NPI 1992293757
$1,282.86
in general payments reported to CMS, 2019-2025
14 companies · $292 in 2025
The $292 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $221 · 2020: $48.25 · 2021: $15.28 · 2022: $209 · 2023: $270 · 2024: $227 · 2025: $292.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $789.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $788.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $375.31 | 2019-2025 | Clareon, Clareon Panoptix Pro, Lensx |
| Carl Zeiss Meditec USA, INC. | $169.00 | 2023 | Lumera 700, Atlas 500, Iolmaster 700 |
| Glaukos Corporation | $140.15 | 2019-2025 | Idosetr |
| Allergan, INC. | $99.99 | 2019 | |
| Alimera Sciences, INC. | $94.40 | 2019 | |
| Abbvie INC. | $75.24 | 2022-2025 | |
| Eyepoint US, INC. | $70.68 | 2022 | |
| New World Medical,INC. | $67.68 | 2022-2023 | |
| Bausch & Lomb Americas INC. | $46.63 | 2023-2024 | Envista Mx60 Iol, Akreos Ao Micro Incision Lens, Totalvisc |
| Biotissue Holdings INC. | $35.65 | 2022-2024 | |
| Oyster Point Pharma, INC. | $35.56 | 2022-2023 | Tyrvaya |
| Rayner Intraocular Lenses Limited | $30.47 | 2024 | Rayone Spheric, Rayner Cataract Set 1, Rayone Emv |
| Rxsight INC | $25.86 | 2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Contact Lens |
| Novartis Pharmaceuticals Corporation | $16.24 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samantha Lacroce listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.